CLINICAL_TRIALS
trial_result
· 2013-11-26
Clinical Trial Update: A Confirmatory Trial of SK-PC-B70M in Mild to Moderate Alzheimer's Disease [Phase 3]
Summary
A Phase 3 confirmatory trial of SK-PC-B70M in mild to moderate Alzheimer's disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: SK Chemicals Co., Ltd. | Conditions: Alzheimer's Disease | Phase 3 | Status: COMPLETED